• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乙酰水杨酸对咽喉疼痛及与急性上呼吸道感染相关的其他疼痛症状的影响。

Effects of acetylsalicylic acid on sore throat pain and other pain symptoms associated with acute upper respiratory tract infection.

作者信息

Eccles Ron, Loose Irene, Jawad Martez, Nyman Lars

机构信息

Common Cold Centre, Cardiff University, UK.

出版信息

Pain Med. 2003 Jun;4(2):118-24. doi: 10.1046/j.1526-4637.2003.03019.x.

DOI:10.1046/j.1526-4637.2003.03019.x
PMID:12873261
Abstract

OBJECTIVE

Acetylsalicylic acid (ASA) has been widely used for over a century to treat pain and fever associated with acute upper respiratory tract infection (URTI), but there is a lack of clinical data to support the efficacy of ASA in this disease state. The objective of this study was to investigate the efficacy and safety of ASA for the treatment of sore throat pain associated with URTI.

DESIGN

A double-blinded, placebo-controlled, parallel group design. Two hundred seventy-two patients (mean age: 25 years) with sore throat pain associated with URTI were recruited at two centers. Pain scores were made during a 2-hour laboratory phase and continued for secondary objectives during a 4-hour home phase. Patients were treated with either two effervescent tablets of ASA 400 mg in water or matched placebo tablets. Patients took medication as required over a 3-day home phase.

RESULTS

ASA was found to be superior to placebo for: The primary efficacy parameter predefined in the protocol, reduction in sore throat pain intensity over 2 hours (P < 0.001), and for secondary efficacy parameters, reduction in sore throat pain intensity over 4 and 6 hours, relief of sore throat pain over 2, 4, and 6 hours, reduction in intensity of pain associated with headache, and reduction in muscle aches and pains over a 2-hour time period (P < 0.01). No safety problems were encountered.

CONCLUSIONS

Treatment with ASA was shown to provide relief from sore throat pain, headache, and muscle aches and pains associated with URTI.

摘要

目的

乙酰水杨酸(ASA)已广泛应用一个多世纪,用于治疗与急性上呼吸道感染(URTI)相关的疼痛和发热,但缺乏临床数据支持ASA在这种疾病状态下的疗效。本研究的目的是调查ASA治疗与URTI相关的咽痛的疗效和安全性。

设计

双盲、安慰剂对照、平行组设计。在两个中心招募了272例(平均年龄:25岁)与URTI相关的咽痛患者。在2小时的实验室阶段进行疼痛评分,并在4小时的家庭阶段继续进行次要目标评估。患者分别接受两片400mg ASA泡腾片溶于水中或匹配的安慰剂片治疗。患者在3天的家庭阶段根据需要服药。

结果

发现ASA在以下方面优于安慰剂:方案中预先定义的主要疗效参数,即2小时内咽痛强度降低(P<0.001);次要疗效参数包括4小时和6小时内咽痛强度降低、2小时、4小时和6小时内咽痛缓解、与头痛相关的疼痛强度降低以及2小时内肌肉疼痛减轻(P<0.01)。未遇到安全问题。

结论

结果表明,ASA治疗可缓解与URTI相关的咽痛、头痛和肌肉疼痛。

相似文献

1
Effects of acetylsalicylic acid on sore throat pain and other pain symptoms associated with acute upper respiratory tract infection.乙酰水杨酸对咽喉疼痛及与急性上呼吸道感染相关的其他疼痛症状的影响。
Pain Med. 2003 Jun;4(2):118-24. doi: 10.1046/j.1526-4637.2003.03019.x.
2
Aspirin compared with acetaminophen in the treatment of fever and other symptoms of upper respiratory tract infection in adults: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group, single-dose, 6-hour dose-ranging study.阿司匹林与对乙酰氨基酚治疗成人发热及上呼吸道感染其他症状的比较:一项多中心、随机、双盲、双模拟、安慰剂对照、平行组、单剂量、6小时剂量范围研究。
Clin Ther. 2005 Jul;27(7):993-1003. doi: 10.1016/j.clinthera.2005.06.002.
3
Efficacy of 8 mg lidocaine and 2 mg cetylpyridinium chloride (CPC) fixed-combination lozenges on sore throat pain intensity compared with 1 mg lidocaine and 2 mg CPC fixed-combination lozenges in subjects with sore throat due to upper respiratory tract infection: a randomized double-blind parallel-group single-dose study.与1毫克利多卡因和2毫克氯化十六烷基吡啶(CPC)固定组合含片相比,8毫克利多卡因和2毫克氯化十六烷基吡啶(CPC)固定组合含片对上呼吸道感染所致喉咙痛患者喉咙痛疼痛强度的疗效:一项随机双盲平行组单剂量研究。
Trials. 2018 Dec 12;19(1):679. doi: 10.1186/s13063-018-3077-6.
4
Efficacy of flurbiprofen 8.75 mg spray in patients with sore throat due to an upper respiratory tract infection: A randomised controlled trial.8.75毫克氟比洛芬喷雾剂治疗上呼吸道感染所致咽痛患者的疗效:一项随机对照试验。
Eur J Gen Pract. 2016 Jun;22(2):111-8. doi: 10.3109/13814788.2016.1145650. Epub 2016 Mar 30.
5
Meaningful relief with flurbiprofen 8.75 mg spray in patients with sore throat due to upper respiratory tract infection.8.75毫克氟比洛芬喷雾剂可有效缓解上呼吸道感染所致咽喉痛患者的症状。
Pain Manag. 2018 Mar;8(2):79-83. doi: 10.2217/pmt-2017-0100. Epub 2018 Jan 29.
6
Clinical, double-blind, placebo-controlled study investigating the combination of acetylsalicylic acid and pseudoephedrine for the symptomatic treatment of nasal congestion associated with common cold.一项临床双盲、安慰剂对照研究,旨在探究乙酰水杨酸与伪麻黄碱联合用药对普通感冒所致鼻充血进行对症治疗的效果。
Arzneimittelforschung. 2004;54(9):513-21. doi: 10.1055/s-0031-1297006.
7
Pain relief of sore throat with a new anti-inflammatory throat lozenge, ibuprofen 25 mg: A randomised, double-blind, placebo-controlled, international phase III study.新型抗炎咽喉含片布洛芬25mg缓解咽喉疼痛:一项随机、双盲、安慰剂对照的国际III期研究
Int J Clin Pract. 2017 Sep;71(9). doi: 10.1111/ijcp.12961. Epub 2017 Sep 4.
8
Kikyo-to vs. Placebo on Sore Throat Associated with Acute Upper Respiratory Tract Infection: A Randomized Controlled Trial.桔梗汤与安慰剂治疗急性上呼吸道感染相关咽喉痛的随机对照试验
Intern Med. 2019 Sep 1;58(17):2459-2465. doi: 10.2169/internalmedicine.2748-19. Epub 2019 Jun 7.
9
Randomised, double-blind, placebo-controlled study of a single dose of an amylmetacresol/2,4-dichlorobenzyl alcohol plus lidocaine lozenge or a hexylresorcinol lozenge for the treatment of acute sore throat due to upper respiratory tract infection.一项关于单剂量安米乐/2,4-二氯苯甲醇加利多卡因锭或己基间苯二酚锭治疗上呼吸道感染引起的急性咽痛的随机、双盲、安慰剂对照研究。
J Pharm Pharm Sci. 2012;15(2):281-94. doi: 10.18433/j31309.
10
Demonstration of the analgesic efficacy and dose-response of acetylsalicylic acid with pseudoephedrine.乙酰水杨酸与伪麻黄碱的镇痛疗效和剂量反应的论证。
J Clin Pharmacol. 2010 Dec;50(12):1429-37. doi: 10.1177/0091270009360978. Epub 2010 Mar 29.

引用本文的文献

1
Supporting respiratory epithelia and lowering inflammation to effectively treat common cold symptoms: A randomized controlled trial.支持呼吸上皮细胞并降低炎症以有效治疗普通感冒症状:一项随机对照试验。
PLoS One. 2024 Nov 27;19(11):e0301959. doi: 10.1371/journal.pone.0301959. eCollection 2024.
2
The 125th Anniversary of Aspirin-The Story Continues.阿司匹林问世125周年——故事仍在继续。
Pharmaceuticals (Basel). 2024 Mar 28;17(4):437. doi: 10.3390/ph17040437.
3
Aromatic ointments for the common cold: what does the science say?用于治疗普通感冒的芳香软膏:科学是怎么说的?
Drugs Context. 2022 Aug 1;11. doi: 10.7573/dic.2022-5-6. eCollection 2022.
4
Nonsteroidal anti-inflammatory drugs in acute viral respiratory tract infections: An updated systematic review.非甾体抗炎药在急性病毒性呼吸道感染中的应用:一项更新的系统评价。
Pharmacol Res Perspect. 2022 Apr;10(2):e00925. doi: 10.1002/prp2.925.
5
Adverse effects of non-steroidal anti-inflammatory drugs in patients with viral respiratory infections: rapid systematic review.非甾体抗炎药在病毒性呼吸道感染患者中的不良反应:快速系统评价。
BMJ Open. 2020 Nov 19;10(11):e040990. doi: 10.1136/bmjopen-2020-040990.
6
Prevalence of Headache in Patients With Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis of 14,275 Patients.2019冠状病毒病(COVID-19)患者头痛的患病率:对14275例患者的系统评价和荟萃分析
Front Neurol. 2020 Nov 27;11:562634. doi: 10.3389/fneur.2020.562634. eCollection 2020.
7
Phenotypic characterization of acute headache attributed to SARS-CoV-2: An ICHD-3 validation study on 106 hospitalized patients.急性头痛的表型特征归因于 SARS-CoV-2:一项对 106 例住院患者的 ICHD-3 验证研究。
Cephalalgia. 2020 Nov;40(13):1432-1442. doi: 10.1177/0333102420965146.
8
Headache in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Narrative Review.严重急性呼吸综合征冠状病毒 2 感染患者的头痛:叙述性综述。
Headache. 2020 Nov;60(10):2131-2138. doi: 10.1111/head.13980. Epub 2020 Oct 5.
9
Factors associated with the presence of headache in hospitalized COVID-19 patients and impact on prognosis: a retrospective cohort study.与住院 COVID-19 患者头痛存在相关的因素及其对预后的影响:一项回顾性队列研究。
J Headache Pain. 2020 Jul 29;21(1):94. doi: 10.1186/s10194-020-01165-8.
10
Is Acetylsalicylic Acid a Safe and Potentially Useful Choice for Adult Patients with COVID-19 ?乙酰水杨酸(阿司匹林)对于 COVID-19 成年患者来说是否安全且可能有效?
Drugs. 2020 Sep;80(14):1383-1396. doi: 10.1007/s40265-020-01365-1.